Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Parsons

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Cancer|May 1, 1981
A comparison of DNA and DNA-binding protein levels in malignant diseaseS A Leon, B Shapiro, P Servi, et al.
Journal of Molecular Biology|June 25, 1974
Letter: Crystallographic data of an L-arabinose-binding protein from Escherichia coliF A Quiocho, G N Phillips, R G Parsons, et al.
British Journal of Cancer|August 1, 1978
Serum ribonuclease activity in cancer patientsR H Kottel, S O Hoch, R G Parsons, et al.
Cancer Research|March 1, 1977
A clinical evaluation of serum C3DP levels in individuals with malignant diseasesR G Parsons, R L Longmire, S O Hoch, et al.
Neuroscience|June 13, 2006
The formation of auditory fear memory requires the synthesis of protein and mRNA in the auditory thalamusR G Parsons, B A Riedner, G M Gafford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1982
Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's typeD Benjamin, I T Magrath, R Maguire, et al.
Journal of the National Cancer Institute|November 1, 1980
Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseasesH D Todd, M S Coffee, T P Waalkes, et al.
Clinical Chemistry|September 1, 1993
Multianalyte assay system developed for drugs of abuseR G Parsons, R Kowal, D LeBlond, et al.
Translational Psychiatry|June 21, 2017
Successful pharmacotherapy for the treatment of severe feeding aversion with mechanistic insights from cross-species neuronal remodelingW G Sharp, A G Allen, K H Stubbs, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Cancer|May 1, 1981
A comparison of DNA and DNA-binding protein levels in malignant diseaseS A Leon, B Shapiro, P Servi, et al.
Journal of Molecular Biology|June 25, 1974
Letter: Crystallographic data of an L-arabinose-binding protein from Escherichia coliF A Quiocho, G N Phillips, R G Parsons, et al.
British Journal of Cancer|August 1, 1978
Serum ribonuclease activity in cancer patientsR H Kottel, S O Hoch, R G Parsons, et al.
Cancer Research|March 1, 1977
A clinical evaluation of serum C3DP levels in individuals with malignant diseasesR G Parsons, R L Longmire, S O Hoch, et al.
Neuroscience|June 13, 2006
The formation of auditory fear memory requires the synthesis of protein and mRNA in the auditory thalamusR G Parsons, B A Riedner, G M Gafford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1982
Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's typeD Benjamin, I T Magrath, R Maguire, et al.
Journal of the National Cancer Institute|November 1, 1980
Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseasesH D Todd, M S Coffee, T P Waalkes, et al.
Clinical Chemistry|September 1, 1993
Multianalyte assay system developed for drugs of abuseR G Parsons, R Kowal, D LeBlond, et al.
Translational Psychiatry|June 21, 2017
Successful pharmacotherapy for the treatment of severe feeding aversion with mechanistic insights from cross-species neuronal remodelingW G Sharp, A G Allen, K H Stubbs, et al.
Pageof 2